Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,010 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas

NCT03576612

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • Abrams Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

NCT01986712

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St Luke's University Hospital and Health Network Bethlehem, Pennsylvania, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)

NCT04438304

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Completed

Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

NCT03665597

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Orange Health Services ( Site 0004) Orange, New South Wales, Australia
  • Calvary Mater Newcastle ( Site 0006) Waratah, New South Wales, Australia
  • Cairns and Hinterland Hospital and Health Service ( Site 0001) Cairns, Queensland, Australia
  • Royal Adelaide Hospital ( Site 0002) Adelaide, South Australia, Australia
View all 15 locations
View Trial Details

Related conditions